My Bibliography

select

LoRusso PM, Gounder M, Jalal SI, André V, Kambhampati SRP, Loizos N, Hall J, Holzer TR, Nasir A, Cosaert J, Kauh J, Chiorean EG. Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors. Invest New Drugs. 2017 Aug;35(4):442-450. doi: 10.1007/s10637-016-0413-0. Epub 2017 Feb 4. PubMed PMID: 28161886; PubMed Central PMCID: PMC5502198.

select

Huang W, Chang CL, Brault ND, Gur O, Wang Z, Jalal SI, Low PS, Ratliff TL, Pili R, Savran CA. Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip device. Lab Chip. 2017 Jan 31;17(3):415-428. doi: 10.1039/c6lc01279e. PubMed PMID: 28054089.

select

Mosher CE, Ott MA, Hanna N, Jalal SI, Champion VL. Development of a Symptom Management Intervention: Qualitative Feedback From Advanced Lung Cancer Patients and Their Family Caregivers. Cancer Nurs. 2017 Jan/Feb;40(1):66-75. doi: 10.1097/NCC.0000000000000350. PubMed PMID: 26925990; PubMed Central PMCID: PMC5001932.

select

Langer CJ, Gadgeel SM, Borghaei H, Papadimitrakopoulou VA, Patnaik A, Powell SF, Gentzler RD, Martins RG, Stevenson JP, Jalal SI, Panwalkar A, Yang JC, Gubens M, Sequist LV, Awad MM, Fiore J, Ge Y, Raftopoulos H, Gandhi L. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. Lancet Oncol. 2016 Nov;17(11):1497-1508. doi: 10.1016/S1470-2045(16)30498-3. Epub 2016 Oct 10. PubMed PMID: 27745820; PubMed Central PMCID: PMC6886237.

select

Xu D, Jalal SI, Sledge GW, Meroueh SO. Small-molecule binding sites to explore protein-protein interactions in the cancer proteome. Mol Biosyst. 2016 Oct 20;12(10):3067-87. doi: 10.1039/c6mb00231e. Epub 2016 Jul 25. PubMed PMID: 27452673; PubMed Central PMCID: PMC5030169.

select

Mosher CE, Winger JG, Hanna N, Jalal SI, Einhorn LH, Birdas TJ, Ceppa DP, Kesler KA, Schmitt J, Kashy DA, Champion VL. Randomized Pilot Trial of a Telephone Symptom Management Intervention for Symptomatic Lung Cancer Patients and Their Family Caregivers. J Pain Symptom Manage. 2016 Oct;52(4):469-482. doi: 10.1016/j.jpainsymman.2016.04.006. Epub 2016 Jul 9. PubMed PMID: 27401514; PubMed Central PMCID: PMC5075493.

select

Mamdani H, Jalal SI. DNA repair in lung cancer: potential not yet reached. Lung Cancer Manag. 2016 Apr;5(1):5-8. doi: 10.2217/lmt-2016-0004. Epub 2016 Apr 6. PubMed PMID: 30643544; PubMed Central PMCID: PMC6310343.

select

Gavande NS, VanderVere-Carozza PS, Hinshaw HD, Jalal SI, Sears CR, Pawelczak KS, Turchi JJ. DNA repair targeted therapy: The past or future of cancer treatment?. Pharmacol Ther. 2016 Apr;160:65-83. doi: 10.1016/j.pharmthera.2016.02.003. Epub 2016 Feb 16. Review. PubMed PMID: 26896565; PubMed Central PMCID: PMC4811676.

select

Bernhardt EB, Jalal SI. Small Cell Lung Cancer. Cancer Treat Res. 2016;170:301-22. doi: 10.1007/978-3-319-40389-2_14. Review. PubMed PMID: 27535400.

select

Huang W, Chang CL, Chan BD, Jalal SI, Matei DE, Low PS, Savran CA. Concurrent Detection of Cellular and Molecular Cancer Markers Using an Immunomagnetic Flow System. Anal Chem. 2015 Oct 20;87(20):10205-12. doi: 10.1021/acs.analchem.5b02215. Epub 2015 Jul 24. PubMed PMID: 26165381.

select

Mamdani H, Induru R, Jalal SI. Novel therapies in small cell lung cancer. Transl Lung Cancer Res. 2015 Oct;4(5):533-44. doi: 10.3978/j.issn.2218-6751.2015.07.20. Review. PubMed PMID: 26629422; PubMed Central PMCID: PMC4630526.

select

Mamdani H, Jalal SI, Hanna N. Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration. Curr Treat Options Oncol. 2015 Oct;16(10):47. doi: 10.1007/s11864-015-0364-2. Review. PubMed PMID: 26233240.

select

Lourdes LS, Jalal SI, Hanna N. Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer. Oncologist. 2015 Sep;20(9):975-8. doi: 10.1634/theoncologist.2015-0182. Epub 2015 Aug 12. PubMed PMID: 26268739; PubMed Central PMCID: PMC4571806.

select

Mosher CE, Ott MA, Hanna N, Jalal SI, Champion VL. Coping with physical and psychological symptoms: a qualitative study of advanced lung cancer patients and their family caregivers. Support Care Cancer. 2015 Jul;23(7):2053-60. doi: 10.1007/s00520-014-2566-8. Epub 2014 Dec 20. PubMed PMID: 25527242; PubMed Central PMCID: PMC4449810.

select

Chang CL, Huang W, Jalal SI, Chan BD, Mahmood A, Shahda S, O'Neil BH, Matei DE, Savran CA. Circulating tumor cell detection using a parallel flow micro-aperture chip system. Lab Chip. 2015 Apr 7;15(7):1677-88. doi: 10.1039/c5lc00100e. PubMed PMID: 25687986.

select

Zhang C, Jalal SI, Zhang S, Wang M, Cheng L. Pulmonary adenocarcinoma with combined ALK translocation and copy number gain: A rare case with treatment response. Lung Cancer Management. 2015; 4(3):125-129.

select

Hardacker TJ, Ceppa D, Okereke I, Rieger KM, Jalal SI, LeBlanc JK, DeWitt JM, Kesler KA, Birdas TJ. Treatment of clinical T2N0M0 esophageal cancer. Ann Surg Oncol. 2014 Nov;21(12):3739-43. doi: 10.1245/s10434-014-3929-6. Epub 2014 Jul 22. PubMed PMID: 25047477.

select

Mosher CE, Winger JG, Hanna N, Jalal SI, Fakiris AJ, Einhorn LH, Birdas TJ, Kesler KA, Champion VL. Barriers to mental health service use and preferences for addressing emotional concerns among lung cancer patients. Psychooncology. 2014 Jul;23(7):812-9. doi: 10.1002/pon.3488. Epub 2014 Feb 3. PubMed PMID: 24493634; PubMed Central PMCID: PMC4082441.

select

Peng X, Wang F, Li L, Bum-Erdene K, Xu D, Wang B, Sinn AA, Pollok KE, Sandusky GE, Li L, Turchi JJ, Jalal SI, Meroueh SO. Exploring a structural protein-drug interactome for new therapeutics in lung cancer. Mol Biosyst. 2014 Mar 4;10(3):581-91. doi: 10.1039/c3mb70503j. Epub 2014 Jan 9. PubMed PMID: 24402119; PubMed Central PMCID: PMC4016822.

select

Dewalt RI, Kesler KA, Hammoud ZT, Baldridge L, Hattab EM, Jalal SI. Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repair. Lung Cancer (Auckl). 2014;5:11-20. doi: 10.2147/LCTT.S57594. eCollection 2014. PubMed PMID: 28210138; PubMed Central PMCID: PMC5217507.

select

Chang C, Jalal SI, Huang W, Mahmood A, Matei DE, Savran CA. High Throughput Immunomagnetic Cell Detection using a microaperture Chip System. IEEE sensors journal. 2014; 14(9):3008.

select

Mosher CE, Hanna N, Jalal SI, Fakiris AJ, Einhorn LH, Birdas TJ, Kesler KA, Champion VL. Support service use and interest in support services among lung cancer patients. Lung Cancer. 2013 Oct;82(1):162-7. doi: 10.1016/j.lungcan.2013.06.020. Epub 2013 Aug 6. PubMed PMID: 23932457; PubMed Central PMCID: PMC3814017.

select

Mosher CE, Champion VL, Hanna N, Jalal SI, Fakiris AJ, Birdas TJ, Okereke IC, Kesler KA, Einhorn LH, Given BA, Monahan PO, Ostroff JS. Support service use and interest in support services among distressed family caregivers of lung cancer patients. Psychooncology. 2013 Jul;22(7):1549-56. doi: 10.1002/pon.3168. Epub 2012 Sep 3. PubMed PMID: 22941782; PubMed Central PMCID: PMC3535684.

select

Riggs H, Jalal SI, Baghdadi TA, Bhatia S, McClean J, Johnson C, Yu M, Taber D, Harb W, Hanna N. Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77. Clin Lung Cancer. 2013 May;14(3):224-9. doi: 10.1016/j.cllc.2012.09.004. Epub 2012 Oct 24. PubMed PMID: 23102811.

select

Mosher CE, Champion VL, Azzoli CG, Hanna N, Jalal SI, Fakiris AJ, Birdas TJ, Okereke IC, Kesler KA, Einhorn LH, Monahan PO, Ostroff JS. Economic and social changes among distressed family caregivers of lung cancer patients. Support Care Cancer. 2013 Mar;21(3):819-26. doi: 10.1007/s00520-012-1585-6. Epub 2012 Sep 4. PubMed PMID: 22945881; PubMed Central PMCID: PMC3560318.

select

Khawaja MR, Ulbright TM, Jalal S. Pulmonary Langerhans cell histiocytosis masquerading as adenocarcinoma of the lung. Clin Adv Hematol Oncol. 2013;11(9):600-1. PubMed PMID: 24887305.

select

Jalal SI, Riggs HD, Melnyk A, Richards D, Agarwala A, Neubauer M, Ansari R, Govindan R, Bruetman D, Fisher W, Breen T, Johnson CS, Yu M, Einhorn L, Hanna N. Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology. Ann Oncol. 2012 Jul;23(7):1730-8. doi: 10.1093/annonc/mdr565. Epub 2011 Dec 9. PubMed PMID: 22156624.

select

Jalal S, Earley JN, Turchi JJ. DNA repair: from genome maintenance to biomarker and therapeutic target. Clin Cancer Res. 2011 Nov 15;17(22):6973-84. doi: 10.1158/1078-0432.CCR-11-0761. Epub 2011 Sep 9. Review. PubMed PMID: 21908578; PubMed Central PMCID: PMC3218201.

select

Neher TM, Bodenmiller D, Fitch RW, Jalal SI, Turchi JJ. Novel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatin. Mol Cancer Ther. 2011 Oct;10(10):1796-806. doi: 10.1158/1535-7163.MCT-11-0303. Epub 2011 Aug 16. PubMed PMID: 21846830; PubMed Central PMCID: PMC3191262.

select

Jalal S, Bedano P, Einhorn L, Bhatia S, Ansari R, Bechar N, Koneru K, Govindan R, Wu J, Yu M, Schneider B, Hanna N. Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: a safety, feasibility, and efficacy study from the Hoosier Oncology Group. J Thorac Oncol. 2010 Dec;5(12):2008-11. doi: 10.1097/JTO.0b013e3181f77b6e. PubMed PMID: 21102263.

select

Jalal S, Waterhouse D, Edelman MJ, Nattam S, Ansari R, Koneru K, Clark R, Richards A, Wu J, Yu M, Bottema B, White A, Hanna N. Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology Group. J Thorac Oncol. 2009 Nov;4(11):1420-4. doi: 10.1097/JTO.0b013e3181b624ae. PubMed PMID: 19701110.

select

Jalal SI, Ademuyiwa FO, Hanna NH. The role of maintenance chemotherapy in advanced nonsmall cell lung cancer. Curr Opin Oncol. 2009 Mar;21(2):110-5. doi: 10.1097/CCO.0b013e328322cf49. Review. PubMed PMID: 19532011.

select

Jalal S, Ansari R, Govindan R, Bhatia S, Bruetman D, Fisher W, Masters G, White A, Stover D, Yu M, Hanna N. Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study. J Thorac Oncol. 2009 Jan;4(1):93-6. doi: 10.1097/JTO.0b013e31818de1e6. PubMed PMID: 19096313.